Home›Liraglutide›Legal status
Educational — Not Legal AdviceReviewed
Is Liraglutide legal? FDA status and US regulatory standing
Current status
FDA-approved. Liraglutide is an FDA-approved drug (status recorded ).
Primary source: www.accessdata.fda.gov
Federal legal status
FDA approval status
Liraglutide is an FDA-approved drug. FDA-approved GLP-1 agonist. Victoza (NDA 022341, Jan 2010) for T2D; Saxenda (NDA 206321, Dec 2014) for weight management. Prescription only.
Also known as
Victoza · Saxenda
Status history
- Liraglutide is an FDA-approved drug. [source]
Frequently asked questions
- Is Liraglutide FDA approved?
- Liraglutide is an FDA-approved drug (status recorded 2010-01-25). Primary source linked on this page.
- Can doctors prescribe Liraglutide?
- Liraglutide is listed as prescription-availability in the PeptideBase library. Prescribing rules vary by state and prescriber licensure — consult a licensed clinician.
PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.
Content review: Regulatory status is sourced from the linked primary records and reviewed by the PeptideBase editorial team. This page is educational — not legal or medical advice. Last reviewed: .